Bruce I. Sachs, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 22,500 shares at $356.75 ($8.0M) on 2023-07-17, disclosed to the SEC on 2023-07-18.
Scheduled sale ($8.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $355.54 | 1,697 | $603K | 7.5% |
| 2 | $355.54 | 1,697 | $603K | 7.5% |
| 3 | $356.75 | 5,711 | $2.0M | 25.4% |
| 4 | $356.75 | 5,711 | $2.0M | 25.4% |
| 5 | $357.29 | 3,842 | $1.4M | 17.1% |
| 6 | $357.29 | 3,842 |
| $1.4M |
| 17.1% |
| Total | $356.75 avg | 22,500 | $8.0M | 100% |
| Filing → |
| VRTX | SELL | 2024-05-24 | $3.2M | — | Filing → |
| VRTX | SELL | 2023-11-08 | $4.3M | — | Filing → |
| VRTX | SELL | 2023-04-14 | $13.9M | — | Filing → |